Invention Grant
- Patent Title: Anti-CD40 antibodies and methods of administering thereof
-
Application No.: US14004552Application Date: 2012-03-12
-
Publication No.: US09987356B2Publication Date: 2018-06-05
- Inventor: Keith A. Reimann , Rijian Wang , Christian P. Larsen
- Applicant: Keith A. Reimann , Rijian Wang , Christian P. Larsen
- Applicant Address: US MA Boston US GA Atlanta
- Assignee: Beth Israel Deaconess Medical Center, Inc.,Emory University
- Current Assignee: Beth Israel Deaconess Medical Center, Inc.,Emory University
- Current Assignee Address: US MA Boston US GA Atlanta
- Agency: Clark & Elbing LLP
- International Application: PCT/US2012/028782 WO 20120312
- International Announcement: WO2012/125569 WO 20120920
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61K45/06 ; A61K31/436 ; C07K16/28 ; A61K38/13 ; A61K39/00
Abstract:
The present invention relates to antibodies specific for a particular epitope on CD40 and antibodies that bind CD40 and have particular functional characteristics. The present invention also relates to fragments of these antibodies, uses of the antibodies for reduction or treatment of transplant rejection and graft-versus-host disease, and methods for making the antibodies.
Public/Granted literature
- US20140093497A1 ANTI-CD40 ANTIBODIES AND USES THEREOF Public/Granted day:2014-04-03
Information query
